Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000373010

Medchemexpress LLC Eltrombopag Olamine | 496775-62-3 | C29H36N6O6 | 1 ML
SDP

Catalog No. 5000373010
Encompass_Preferred

Eltrombopag Olamine is an orally active, nonpeptide agonist of the thrombopoietin receptor. It exhibits thrombopoietic activity and has been investigated for its use in treating low blood platelet counts associated with chronic immune thrombocytopenia. Additionally, it is being researched for cardiovascular applications and has demonstrated significant inhibitory effects against multidrug-resistant Staphylococcus aureus. It can also induce apoptosis in hepatocellular carcinoma (HCC) cells.

  • Orally active thrombopoietin receptor nonpeptide agonist
  • Exhibits thrombopoietic activity
  • Highly inhibitory against multidrug-resistant Staphylococcus aureus
  • Induces apoptosis in hepatocellular carcinoma (HCC) cells
  • Activates p-STAT5 and stimulates cell proliferation
  • Increases differentiation of bone marrow CD34+ cells
  • Exhibits antiapoptotic effects in N2C-Tpo cells

Catalog No. 50-003-73010 Supplier Medchemexpress LLC Supplier No. HY15306A10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Eltrombopag Olamine is an orally active, nonpeptide agonist of the thrombopoietin receptor. It exhibits thrombopoietic activity and has been investigated for its use in treating low blood platelet counts associated with chronic immune thrombocytopenia. Additionally, it is being researched for cardiovascular applications and has demonstrated significant inhibitory effects against multidrug-resistant Staphylococcus aureus. It can also induce apoptosis in hepatocellular carcinoma (HCC) cells.

  • Orally active thrombopoietin receptor nonpeptide agonist
  • Exhibits thrombopoietic activity
  • Highly inhibitory against multidrug-resistant Staphylococcus aureus
  • Induces apoptosis in hepatocellular carcinoma (HCC) cells
  • Activates p-STAT5 and stimulates cell proliferation
  • Increases differentiation of bone marrow CD34+ cells
  • Exhibits antiapoptotic effects in N2C-Tpo cells

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.